tiprankstipranks
Trending News
More News >
GlaxoSmithKline (GSK)
NYSE:GSK
US Market

GlaxoSmithKline (GSK) Income Statement

Compare
5,175 Followers

GlaxoSmithKline Income Statement

Last quarter (Q3 2025), GlaxoSmithKline's total revenue was £8.55B, an increase of 6.68% from the same quarter last year. In Q3, GlaxoSmithKline's net income was £2.01B. See GlaxoSmithKline’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 31.38B£ 30.33B£ 29.32B£ 24.70B£ 24.35B
Gross Profit
£ 22.33B£ 21.76B£ 19.77B£ 16.53B£ 16.43B
Operating Expenses
£ 18.31B£ 15.02B£ 13.34B£ 12.18B£ 10.45B
Depreciation and Amortization
£ 2.55B£ 2.29B£ 2.15B£ 2.12B£ 2.05B
EBITDA
£ 6.67B£ 9.08B£ 8.60B£ 6.49B£ 8.07B
Operating Income
£ 4.02B£ 6.75B£ 6.43B£ 4.36B£ 5.98B
Other Income/Expenses
£ -544.00M£ -681.00M£ -805.00M£ -758.00M£ -809.00M
Pretax Income
£ 3.48B£ 6.06B£ 5.63B£ 3.60B£ 5.17B
Net Income
£ 2.58B£ 4.93B£ 14.96B£ 4.38B£ 5.75B
Per Share Metrics
Basic EPS
£ 1.26£ 2.44£ 2.44£ 2.74£ 2.88
Diluted EPS
£ 1.24£ 2.40£ 2.40£ 2.70£ 2.86
Weighted Average Shares Outstanding
2.04B 2.03B 2.01B 1.60B 1.99B
Weighted Average Shares Outstanding (Diluted)
2.07B 2.06B 2.04B 1.62B 2.02B
Currency in GBP

GlaxoSmithKline Earnings and Revenue History